Menu

OSTEOMYELITIS:
WHY USE CERAMENT

CERAMENT®|G and CERAMENT® V
augments the management of osteomyelitis

Dead space management

High local concentration of antibiotic

Remodels into bone within 6 -12 months

The quality of the debridement is the most critical factor in successful management of osteomyelitis, but filling the dead space left behind by removal of bone is essential to reduce the risk of recurrence, and the formation of new host bone is critical to reducing the risk of recurrence and fracture.

In a study published by the Oxford Bone Infection Unit, 100 patients with chronic osteomyelitis treated by single-stage surgery and implantation of CERAMENT|G had a 96% eradication of infection at one year. In a comparative study of three different absorbable antibiotic carriers at the same centre, the fracture rate for CERAMENT was half that of the other carriers evaluated.

REFERENCES

Cierny G & Mader JT. The surgical treatment of adult osteomyelitis. In: Evarts CM, et al., eds. Surgery of the musculoskeletal system. Vol. 4. New York: Churchill Livingstone, 1983:10:15-35.

Tetsworth K & Cierny G 3d. Osteomyelitis debridement techniques. Clin Orthop 1999;(360):87-96.

Martin M & Nagarajah K. Osteomyelitis. Ortho Trauma 24:6, 416-429

488. PR 0488-01 en EU McNally et al. A comparative study of three resorbable antibiotic carriers.

McNally et al. Single-stage treatment of chronic osteomyelitis with a new absorbable gentamicin loaded CaS-HA - first 100 cases, Bone Joint J 2016;98-B:1289–96.